Groove Biopharma, Inc.: Series B $6M

Posted in I - Series B, Q - 4Q11, R - NORTH WEST, X - Antiinfective, X - Fibrosis, X - Oncology, X - miRNA, XX - WA

Groove Biopharma (Seattle, WA) a development-stage biopharmaceutical company focused on microRNA therapeutics for cancer, fibrosis and infectious disease, closed a $6M Series B financing. Participants include Amgen Ventures, Versant Ventures, Alexandria Real Estate Equities, ARCH Venture Partners, OVP Venture Partners and WRF Capital.

Mar

2011

HTG, Inc.: Series D $15.7M

Posted in I - Series D, Q - 1Q11, R - SOUTH WEST, X - Device (Diagnostic), X - mRNA, X - miRNA, XX - AZ

HTG (Tuscon, AZ) a commercial-stage molecular technology company focused on gene expression profiling, miRNA and mRNA measurement, translational medicine and diagnostic applications, closed a $15.7M Series D financing. Participants include Novo Ventures, Fletcher Spaght Ventures, Merck Capital Ventures, Solstice Capital and Valley Ventures.

Mar

2010

Sistemic, Ltd.: Series A $1M

Posted in I - Series A, Q - 1Q10, R - INTERNATIONAL, X - miRNA

Sistemic (Scotland) a development-stage biopharma focused on miRNA expression profiling, closed a $1M series A financing. Participants include ChimeraBio and Scottish Enterprise Co-Investment Fund.

Jun

2009

miRagen Therapeutics, Inc.: Series A $4M

Posted in I - Series A, Q - 2Q09, R - ROCKY MOUNTAIN, X - Cardiology, X - miRNA

miRagen Therapeutics (Boulder, CO) a preclinical-stage biopharmaceutical company focused on the development of miRNA therapeutics for cardiovascular and muscle diseases, closed a $4 Series B, bringing the total round financing to $12M. Participants include Boulder Ventures, Amgen Ventures, Broadview Ventures, The Peierls Foundation and Atlas Venture.

Nov

2008

Miragen, Inc.: Series A $8M

Posted in I - Series A, Q - 2Q08, R - ROCKY MOUNTAIN, X - Cardiology, X - RNAi, X - miRNA

Miragen (Boulder, CO) development-stage company focused on the treatment of cardiovascular and muscle disease based on microRNA biology, closed a $8M Series A financing. Participants include Atlas Venture and Boulder Ventures.

to top of page...